"Innovative Market Solutions to Help Businesses Make Informed Decisions"
Sodium hyaluronate is the sodium salt of hyaluronic acid. It is a type of glycosaminoglycan, that is naturally found in connective tissues of human body. The polyanionic form of sodium hyaluronate is referred as hyaluronan which is a visco-elastic polymer found in eyes and fluid present in the joints. It functions as a tissue lubricant in controlling the exchanges that take place between adjacent tissues.
Increasing ophthalmic conditions in geriatric population is boosting the market growth. Sodium hyaluronate is used as an aid in ophthalmic surgeries like cataract extraction, corneal transplant, intraocular lens implantation, retina attachment surgery and others. Additionally, it is also used in skin injections that are used in plastic surgeries as dermal filler. The use of sodium hyaluronate in pharmaceuticals as nano carrier is expected to drive the market growth.
However, it can cause some side effects like post-operative inflammation and corneal edema which is expected to hamper the market growth.
Key Market Driver -
Increasing number of patients with ophthalmic conditions.
Key Market Restraint -
Side effects like post-operative inflammation.
Based on type, the market is segmented into intra-articular injection, ophthalmic visco-surgical devices, anti-adhesive products, derma fillers, scaffold materials, and others. Based on application, the market is segmented into, ophthalmology, cosmetic surgery, osteoarthritis, and others.
From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The global medical grade sodium hyaluronate market consists of global & regional players operating. Some of the key players in the market include, LG Group, Allergan, Altergon Italia, Beauty Aesthetic Finland, RiverPharma, Qufu Guanglong Biochemical Factory, HUONS, Haohai Biological Technology, Stanford Chemicals, and others.
The market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to hold the largest share attributed to the huge investment of government in R&D for medical and healthcare. Asia Pacific is estimated to be second-largest market due to the easy availability of raw material and labor. Europe is expected to show significant growth due to the technological advancement in operating and treatment procedures of diseases and medical conditions. Latin America and Middle East and Africa are expected to show considerable growth by the end of the forecast period.
To gain extensive insights into the market, Request for Customization
ATTRIBUTE | DETAILS |
By Type |
|
By Application |
|
By Geography |
|
US +1 833 909 2966 ( Toll Free )